跳至主要内容
临床试验/DRKS00024153
DRKS00024153招募中不适用

on-interventional Study on the Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Daiichi Sankyo Europe0 个研究点目标入组 4,250 人开始时间: 2021年1月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
4,250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Written informed consent to participate
  • At least 18 years of age
  • Patients suffering from documented hypercholesterolemia or mixed dyslipidemia treated or intended to be treated with bempedoic acid/ FDC at the discretion of the physician are appropriate for participation in the observation.
  • No contraindications exist according to the SmPC of bempedoic acid/ FDC
  • No concurrent participation in an interventional study (Simultaneous participation in other non-interventional studies is possible)
  • Life expectancy > 1 year

排除标准

  • As this is a non-interventional study, no explicit exclusion criteria are defined.

研究者

发起方
Daiichi Sankyo Europe

相似试验